BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
CONDITION

Evidence-Based Compounds for ADHD

ADHD involves dysregulation of dopamine and norepinephrine signalling in prefrontal cortex circuits governing executive function, attention, and impulse control. Research identifies several compounds with evidence for improving attention, reducing hyperactivity, and supporting dopamine/norepinephrine metabolism as adjuncts to standard care.

Ranking Methodology
Compounds are ranked using a four-signal weighted model: BiohacksAI discovery score (cross-study convergence across targets), target match (direct overlap with DRD1, DRD2, DRD4 and related targets — highest differentiating signal), pathway overlap with DOPAMINE SEROTONIN and NEUROTROPHIC pathways, and PubMed study count (log-scaled). Clinical drugs are excluded.
Key Biological Targets

Click a target to see all compounds with documented interactions in the BiohacksAI corpus.

Related Conditions

This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.

Browse all compounds · Biological pathways · Molecular targets · All conditions

© Organiq Sweden AB · Patent pending EVE-PAT-2026-001